AQST (Aquestive Pharma) Gross Profit Margin

Aquestive Therapeutics (AQST) is based on PharmFilm patents, replacing injections with convenient oral films. Specific temperature-controlled logistics increase delivery costs, while robotic lines automate the cutting of strips. This gross profit margin chart visualizes the efficiency of these processes, where the 65.30 mark records this metric, helping to separate the real profitability signal from market noise.
Comprehensive metric breakdowns and analytics for Aquestive Therapeutics (AQST)

Gross margin measures production efficiency by determining the profit share after deducting direct costs of goods sold. By analyzing the gross profit margin, an investor assesses the pricing power of Aquestive Therapeutics (AQST), which is supported by unique soluble films that extend drug lifecycles and create barriers for generics, ensuring a consistently high level of business profitability.